Effects of switching from oral administration to intravenous injection of l-carnitine on lipid metabolism in hemodialysis patients

K Fukami, S Yamagishi, K Sakai, M Nasu… - Clinical kidney …, 2014 - academic.oup.com
Background Carnitine deficiency may contribute to cardiovascular disease (CVD) in patients
with hemodialysis (HD). Dyslipidemia plays a role in CVD and its prevalence is also high in …
被引用次数：21 相关文章

Effects of switching from oral administration to intravenous injection of l-carnitine on lipid metabolism in hemodialysis patients.

K Fukami, S Yamagishi, K Sakai… - Clinical Kidney …, 2014 - search.ebscohost.com
Background Carnitine deficiency may contribute to cardiovascular disease (CVD) in patients
with hemodialysis (HD). Dyslipidemia plays a role in CVD and its prevalence is also high in …

Effects of switching from oral administration to intravenous injection of L-carnitine on lipid metabolism in hemodialysis patients.

K Fukami, S Yamagishi, K Sakai, M Nasu, S Okuda - 2014 - cabidigitallibrary.org
Background: Carnitine deficiency may contribute to cardiovascular disease (CVD) in
patients with hemodialysis (HD). Dyslipidemia plays a role in CVD and its prevalence is also …

[引用][C] Effects of switching from oral administration to intravenous injection of L-carnitine on lipid metabolism in hemodialysis patients

K Fukami, S Yamagishi, K Sakai, M Nasu… - Clinical Kidney …, 2014 - cir.nii.ac.jp
Effects of switching from oral administration to intravenous injection of L-carnitine on lipid
metabolism in hemodialysis patients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
[PDF] psu.edu

[PDF][PDF] Effects of switching from oral administration to intravenous injection of L-carnitine on lipid metabolism in hemodialysis patients

K Fukami, S Yamagishi, K Sakai, M Nasu, S Okuda - 2014 - Citeseer
Background. Carnitine deficiency may contribute to cardiovascular disease (CVD) in
patients with hemodialysis (HD). Dyslipidemia plays a role in CVD and its prevalence is also …

Effects of switching from oral administration to intravenous injection of l-carnitine on lipid metabolism in hemodialysis patients.

K Fukami, S Yamagishi, K Sakai, M Nasu… - Clinical Kidney …, 2014 - europepmc.org
Background Carnitine deficiency may contribute to cardiovascular disease (CVD) in patients
with hemodialysis (HD). Dyslipidemia plays a role in CVD and its prevalence is also high in …
[PDF] semanticscholar.org

[PDF][PDF] Effects of switching from oral administration to intravenous injection of L-carnitine on lipid metabolism in hemodialysis patients

K Fukami, S Yamagishi, K Sakai, M Nasu, S Okuda - 2014 - pdfs.semanticscholar.org
Background. Carnitine deficiency may contribute to cardiovascular disease (CVD) in
patients with hemodialysis (HD). Dyslipidemia plays a role in CVD and its prevalence is also …
[HTML] nih.gov

[HTML][HTML] Effects of switching from oral administration to intravenous injection of l-carnitine on lipid metabolism in hemodialysis patients

K Fukami, S Yamagishi, K Sakai, M Nasu… - Clinical Kidney …, 2014 - ncbi.nlm.nih.gov
Background Carnitine deficiency may contribute to cardiovascular disease (CVD) in patients
with hemodialysis (HD). Dyslipidemia plays a role in CVD and its prevalence is also high in …

Effects of switching from oral administration to intravenous injection of l-carnitine on lipid metabolism in hemodialysis patients

K Fukami, SI Yamagishi, K Sakai… - Clinical kidney …, 2014 - pubmed.ncbi.nlm.nih.gov
Background Carnitine deficiency may contribute to cardiovascular disease (CVD) in patients
with hemodialysis (HD). Dyslipidemia plays a role in CVD and its prevalence is also high in …